Literature DB >> 5952076

An extended study of indomethacin. II. Clinical therapy.

N O Rothermich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5952076

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Trial of an anti-inflammatory agent (indomethacin) in low back pain with and without radicular involvement.

Authors:  J H Jacobs; M F Grayson
Journal:  Br Med J       Date:  1968-07-20

2.  Evaluation of indomethacin.

Authors:  J J Calabro
Journal:  Can Med Assoc J       Date:  1968-06-01       Impact factor: 8.262

3.  Indomethacin and acetylsalicylic acid in the treatment of osteoarthritis of the hips and knees.

Authors:  M Harth; D C Bondy
Journal:  Can Med Assoc J       Date:  1969-09-20       Impact factor: 8.262

4.  Alteration of plasma prednisolone levels by indomethacin and naproxen.

Authors:  S A Rae; I A Williams; J English; E M Baylis
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

5.  An investigation of the prevalence and significance of gastric parietal-cell autoantibody in rheumatoid arthritis.

Authors:  E M Armstrong
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

6.  Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects.

Authors:  Md Tariqul Haque Tuhin; Dengpan Liang; Fang Liu; Hala Aldawod; Toufiq Ul Amin; Joshua S Ho; Rasha Emara; Arjun D Patel; Melanie A Felmlee; Miki S Park; James A Uchizono; Mamoun M Alhamadsheh
Journal:  Nat Commun       Date:  2022-06-23       Impact factor: 17.694

7.  The run-in period in trial design: a comparison of two non-steroidal anti-inflammatory agents in psoriatic arthropathy.

Authors:  P A Leatham; H A Bird; V Wright; P D Fowler
Journal:  Agents Actions       Date:  1982-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.